Screening compound: UFTRRJLJSINTRU-LJQANCHMSA-N

Screening compound: UFTRRJLJSINTRU-LJQANCHMSA-N
Screening compound: UFTRRJLJSINTRU-LJQANCHMSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
UFTRRJLJSINTRU-LJQANCHMSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C202-3763

Molecular Formula

C20H19N3 (C20 H19 N3)

Compound Name

12-phenyl-1,2,3,4,5,12-hexahydro[1,3]benzimidazo[2,1-b]quinazoline

IUPAC name

9-phenyl-21017-triazatetracyclo[8.7.0.0^{38}.0^{1116}]heptadeca-1(17)3(8)111315-pentaene

SMILES

C(CC1)CC2=C1Nc1nc(cccc3)c3n1C2c1ccccc1

InChI

InChI=1S/C20H19N3/c1-2-8-14(9-3-1)19-15-10-4-5-11-16(15)21-20-22-17-12-6-7-13-18(17)23(19)20/h1-3,6-9,12-13,19H,4-5,10-11H2,(H,21,22)/t19-/m1/s1

InChI Key

UFTRRJLJSINTRU-LJQANCHMSA-N

MDL Number (MFCD)

MFCD01627162

UFTRRJLJSINTRU-LJQANCHMSA-N in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

DGK Inhibitors Library (10558 compounds)

GPCR Targeted Library (31838 compounds)

KRAS-Targeted Library (16000 compounds)

Nucleic Acid Ligands (8311 compounds)

Targeted Diversity Library (40567 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Mechanism of action:
  • Epigenetic
  • Receptor's ligands
Targets:
  • Kinases
  • GPCR
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with UFTRRJLJSINTRU-LJQANCHMSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound UFTRRJLJSINTRU-LJQANCHMSA-N?
Check Price and Availability of UFTRRJLJSINTRU-LJQANCHMSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of UFTRRJLJSINTRU-LJQANCHMSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for UFTRRJLJSINTRU-LJQANCHMSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for UFTRRJLJSINTRU-LJQANCHMSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of UFTRRJLJSINTRU-LJQANCHMSA-N available by request